Bausch + Lomb (BLCO)
(Delayed Data from NYSE)
$15.53 USD
-0.64 (-3.96%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $15.52 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
Price, Consensus and EPS Surprise
BLCO 15.53 -0.64(-3.96%)
Will BLCO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BLCO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BLCO
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
BLCO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
BLCO vs. AVTR: Which Stock Is the Better Value Option?
All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy
Other News for BLCO
Bausch Health price target lowered by $1 at Truist, here's why
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Strong Performance and Promising Outlook Justify Buy Rating for Bausch + Lomb
Bausch + Lomb price target raised by $2 at RBC Capital, here's why
Bausch + Lomb Corporation (BLCO) Gets a Buy from RBC Capital